Total synthesis of marinomycin A using salicylate as a molecular switch to mediate dimerization

Abstract

Antibiotics play a significant role in human health because of their ability to treat life-threatening bacterial infections. The growing problems with antibiotic resistance have made the development of new antibiotics a World Health Organization priority. Marinomycin A is a member of a new class of bis-salicylate-containing polyene macrodiolides, which have potent antibiotic activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. Herein, we describe a triply convergent synthesis of this agent using the salicylate as a novel molecular switch for the chemoselective construction of the macrodiolide. This strategy raises new questions regarding the biosynthetic role of the salicylate and its potential impact on the mechanism of action of these types of agents. For instance, in contrast to penicillin, which enhances the electrophilicity of the cyclic amide through ring strain, salicylates reduce the electrophilicity of the aryl ester through an intramolecular resonance-assisted hydrogen bond to provide an amide surrogate. Marinomycin A is a member of a new class of bis-salicylate-containing polyene macrodiolide, with potent antibiotic activity against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREF). Here, a triply convergent synthesis of this agent is described that uses the salicylate moiety as a novel molecular switch for the chemoselective construction of the macrodiolide.

Cite this article

Evans, P., Huang, MH., Lawler, M. et al. Total synthesis of marinomycin A using salicylate as a molecular switch to mediate dimerization. Nature Chem 4, 680–684 (2012). https://doi.org/10.1038/nchem.1330

View full text

>> Full Text:   Total synthesis of marinomycin A using salicylate as a molecular switch to mediate dimerization